CD22 / HRP / hL22 (Epratuzumab)
CD22 / HRP / hL22 (Epratuzumab)
Product Details
| Supplier | Absolute Antibody | |
|---|---|---|
| Catalog #: | Ab00728-10.0-hrp (View supplier product page) | |
| Size | 200 μg | |
| Price | ||
| Antigen | CD22 | |
| Clone | hL22 (Epratuzumab) | |
| Host | Human | |
| Isotype | IgG1 | |
| Conjugate | HRP | |
| Target Species | Cynomolgus macaque, Human, Rhesus macaque | |
| Applications | Block/Neutralize, IP, FC | |
| Description | Anti-CD22 [hL22 (Epratuzumab)] |
About CD22 and HRP
| CD22 | Predicted to enable CD4 receptor binding activity; protein phosphatase binding activity; and sialic acid binding activity. Involved in B cell activation; negative regulation of B cell receptor signaling pathway; and regulation of endocytosis. Located in early endosome and recycling endosome. [provided by Alliance of Genome Resources, Apr 2022] |
|---|
Citations
| Additional Sources |
|
|---|
